Hartmut Gobel

Summary

Affiliation: Neurologisch-verhaltensmedizinische Schmerzklinik Kiel
Country: Germany

Publications

  1. doi request reprint [Integrated headache care network. Kiel Migraine and Headache Center and German National Headache Treatment Network]
    H Gobel
    Migräne und Kopfschmerzzentrum, Schmerzklinik Kiel, Heikendendorfer Weg 9 27, Kiel, Germany
    Schmerz 27:149-65. 2013
  2. doi request reprint [Headache from increased cerebrospinal fluid pressure]
    H Gobel
    Migräne und Kopfschmerzzentrum, Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 26:331-40; quiz 341. 2012
  3. doi request reprint [Botulinum toxin type A for preventive treatment of chronic migraines]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    HNO 60:490-5. 2012
  4. ncbi request reprint [Acetylsalicylic acid in self-medication of migraine. A pharmacy-based observational study]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik, Kiel, Deutschland
    Schmerz 21:49-54, 56. 2007
  5. ncbi request reprint [Prophylactic measures and acute treatment of migraine]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149 Kiel, Deutschland
    Schmerz 20:541-54; quiz 555-6. 2006
  6. ncbi request reprint [Update: migraine therapy 2007]
    Göbel Hartmut
    MMW Fortschr Med 149:79-82. 2007
  7. ncbi request reprint [Headache and facial pain in the elderly]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149 Kiel, Deutschland
    Schmerz 21:561-9; quiz 570-1. 2007
  8. doi request reprint [Development and implementation of integrated health care in pain medicine : the nationwide German headache treatment network]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 23:653-70. 2009
  9. ncbi request reprint [Migraine therapy in general practice 2006]
    Hartmut Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel
    MMW Fortschr Med . 2006
  10. doi request reprint Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis
    Hartmut Gobel
    Kiel Headache Center, Heikendorfer Weg 9 27, D 24149 Kiel, Germany
    Expert Rev Neurother 10:499-506. 2010

Detail Information

Publications36

  1. doi request reprint [Integrated headache care network. Kiel Migraine and Headache Center and German National Headache Treatment Network]
    H Gobel
    Migräne und Kopfschmerzzentrum, Schmerzklinik Kiel, Heikendendorfer Weg 9 27, Kiel, Germany
    Schmerz 27:149-65. 2013
    ..This concept offers for the first time a nationwide coordinated treatment without limitation by specialization and bureaucratic remuneration sectors...
  2. doi request reprint [Headache from increased cerebrospinal fluid pressure]
    H Gobel
    Migräne und Kopfschmerzzentrum, Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 26:331-40; quiz 341. 2012
    ..Symptoms include diffuse headache worsening in the morning and with the Valsalva-like maneuver. Treatment is guided by etiology whenever possible; otherwise, drainage of CSF by ventriculostomy or shunt is necessary...
  3. doi request reprint [Botulinum toxin type A for preventive treatment of chronic migraines]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    HNO 60:490-5. 2012
    ..Botox® was licensed in England for the prophylaxis of headaches in adults with chronic migraines (headaches on at least 15 days per month of which at least 8 days are with migraines) in 2010...
  4. ncbi request reprint [Acetylsalicylic acid in self-medication of migraine. A pharmacy-based observational study]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik, Kiel, Deutschland
    Schmerz 21:49-54, 56. 2007
    ....
  5. ncbi request reprint [Prophylactic measures and acute treatment of migraine]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149 Kiel, Deutschland
    Schmerz 20:541-54; quiz 555-6. 2006
    ..Due to an extensive and successful study program topiramate has been officially approved in Germany...
  6. ncbi request reprint [Update: migraine therapy 2007]
    Göbel Hartmut
    MMW Fortschr Med 149:79-82. 2007
    ..Primarily patients who have a high frequency of attacks or for whom triptans are contraindicated, not effective or not tolerated must rely on prophylactic migraine medications. Behavioural measures should accompany preventive medication...
  7. ncbi request reprint [Headache and facial pain in the elderly]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149 Kiel, Deutschland
    Schmerz 21:561-9; quiz 570-1. 2007
    ..In drug treatment of headaches in the elderly, an impairment of renal and/or hepatic function has to be taken in account, as should be the potential multimorbidity of elderly patients...
  8. doi request reprint [Development and implementation of integrated health care in pain medicine : the nationwide German headache treatment network]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 23:653-70. 2009
    ..Patient satisfaction is very high. The healthcare providers may directly participate in treatment success through risk-sharing...
  9. ncbi request reprint [Migraine therapy in general practice 2006]
    Hartmut Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel
    MMW Fortschr Med . 2006
    ..Moreover, there are different pharmaceutical forms. Triptans are contraindicated for coronary, cerebral and peripheral vascular diseases and, likewise, during pregnancy. They are not suitable for emergency treatment...
  10. doi request reprint Efficacy and tolerability of rizatriptan 10 mg compared with sumatriptan 100 mg: an evidence-based analysis
    Hartmut Gobel
    Kiel Headache Center, Heikendorfer Weg 9 27, D 24149 Kiel, Germany
    Expert Rev Neurother 10:499-506. 2010
    ..Owing to the limited efficacy of sumatriptan, a more effective triptan treatment is needed in the majority of patients with acute migraine attacks...
  11. doi request reprint Fabry disease in Spain: description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)
    M A Barba-Romero
    Department of Internal Medicine, Albacete University Hospital, Albacete, Spain
    Int J Clin Pract 65:903-10. 2011
    ..We report the clinical characteristics of Spanish patients enrolled on the Fabry Outcome Survey (FOS; an international multicentre registry for the disease) and also compare these data with those from the rest of Europe...
  12. doi request reprint Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis
    B Singer
    MS Center for Innovations in Care, Missouri Baptist Medical Center, St Louis, MO 63131, USA
    Int J Clin Pract 65:887-95. 2011
    ..In addition to high efficacy with a relatively acceptable safety profile, fingolimod provides a therapy with a new mechanism of action...
  13. doi request reprint The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study
    H Gobel
    Kiel Headache and Pain Centre, Schmerzklinik Kiel, Kiel, Germany
    Int J Clin Pract 65:879-86. 2011
    ..The objective of this study was to determine if MIS could be used to improve the efficacy of frovatriptan 2.5 mg in the early treatment of migraine attacks for clinical practice...
  14. doi request reprint [Chronic migraine and headache by medication overuse. Evolution and revision of classification]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 25:493-500. 2011
    ..An overview of the evolution of the diagnostic criteria for both headache disorders in recent years is provided...
  15. doi request reprint [Botulinum toxin type A in the prophylactic treatment of chronic migraine]
    H Gobel
    Migräne und Kopfschmerzzentrum, Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 25:563-70; quiz 571. 2011
    ..Botox® has been licensed in England for the prophylaxis of headaches in adults with chronic migraine in 2010. Approval for its use in Germany has been applied for...
  16. doi request reprint [Paroxysmal hemicrania and SUNCT]
    H Gobel
    Migräne und Kopfschmerzzentrum, Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel, Deutschland
    Schmerz 25:689-701. 2011
    ..These patients should receive both diagnoses. It is important to differentiate these headache entities as specific therapy is needed for each to achieve optimal pain relief...
  17. ncbi request reprint Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study
    Hartmut Gobel
    Kiel Pain Centre, Heikendorfer Weg 9 27, 24149 Kiel, Germany
    Pain 125:82-8. 2006
    ..Injections were well tolerated...
  18. ncbi request reprint Non pharmaceutical treatments for migraine
    H Gobel
    Kiel Neurological Pain Centre, Kiel, Germany
    Rev Neurol (Paris) 161:685-6. 2005
    ..There are three available strategies: prevention by avoiding trigger factors, prevention via reduction of attack readiness and treatment of the acute effects of the migraine attack...
  19. ncbi request reprint Efficacy of phenazone in the treatment of acute migraine attacks: a double-blind, placebo-controlled, randomized study
    H Gobel
    Kiel Pain Clinic, Germany
    Cephalalgia 24:888-93. 2004
    ..No serious adverse events occurred. The results show that phenazone at a dosage of 1000 mg is effective and well tolerated in the treatment of acute migraine attacks...
  20. ncbi request reprint Botulinum toxin in migraine prophylaxis
    Hartmut Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149 Kiel, Germany
    J Neurol 251:I8-11. 2004
    ....
  21. doi request reprint [Preventive medication in migraine headache : Individualized clinical pathways]
    A Heinze
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel
    Schmerz 24:73-9; quiz 80. 2010
    ..The treatment algorithm presented here tries to bridge the gulf between general treatment guidelines and the actual needs of the patient. From this, feasible clinical pathways are derived for individualized treatment...
  22. ncbi request reprint [Therapy of severe migraine attacks: practical tips]
    Hartmut Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel
    MMW Fortschr Med 147:21-2, 24-6. 2005
    ..Triptans are not suitable for treating status migrainosus. Sumatriptan can be administered electively and in compliance with the contraindications for the emergency treatment...
  23. ncbi request reprint [Dealing with migraines]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Germany
    Schmerz 16:59-81. 2002
  24. ncbi request reprint [Specialised pain therapy: does it pay for patients and health authorities?]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Universitat Kiel
    Schmerz 15:103-9. 2001
    ..Parameters of cost efficacy in pain treatment include pain reduction, reduction of drug intake, increase of physical activity, improvement of quality of life, reduction of inability to work, avoidance of early retirement...
  25. ncbi request reprint [Epidemiology and costs of chronic pain syndromes exemplified by specific and unspecific low back pain]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Universitat Kiel
    Schmerz 15:92-8. 2001
    ..Psychosocial factors are essential for the chronification and must be take into account in therapy. Conventional therapy has shown low efficacy, especially once chronification has started...
  26. ncbi request reprint [Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel in Kooperation mit der Universität Kiel, Heikendorfer Weg 9 27, 24149 Kiel
    Nervenarzt 72:261-74. 2001
    ..The results and experiences obtained so far present new alternatives in the treatment of chronic pain disorders. The practical use of botulinum toxin A is demonstrated...
  27. ncbi request reprint [Managing the attacks, preventing headache. Migraine therapy in 2002]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel
    MMW Fortschr Med . 2002
    ..The article provides an up-to-date overview of the efficacy and tolerability of the various migraine prophylactics...
  28. ncbi request reprint [Prophylactic drug management of migraine]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel in Kooperation mit der Universität Kiel, Germany
    Schmerz 16:223-40. 2002
    ..The paper gives an overview of the efficacy and tolerability of drugs used in migraine prophylaxis...
  29. ncbi request reprint [Botulinum toxin in specific pain therapy]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel
    Schmerz 17:149-65. 2003
    ..However, its use calls for detailed knowledge of functional neuroanatomy and extensive practical experience and expertise...
  30. ncbi request reprint [Treatment of migraine: analgetic plus antiemetic or tryptan]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Universitat Kiel, Heikendorfer Weg 9 27, D 24149 Kiel
    MMW Fortschr Med 145:72-8. 2003
    ..When migraine occurs on more than seven days a month, prophylactic measures are indicated with the aim of preventing drug-induced headache. The objective is a 50% reduction in the number of attacks...
  31. ncbi request reprint [Prophylactic drug management of migraine]
    H Gobel
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel and Universität Kiel
    Nervenarzt 74:915-32; quiz 933-4. 2003
    ..The paper gives an overview of the efficacy and tolerability of drugs used in migraine prophylaxis...
  32. ncbi request reprint [Classification of headache disorders]
    A Heinze
    Neurologisch verhaltensmedizinische Schmerzklinik Kiel, Heikendorfer Weg 9 27, 24149, Kiel
    Schmerz 21:263-73; quiz 274. 2007
    ..Both, the differentiation between secondary and primary headaches and the differentiation between the various primary headaches are of equal importance...
  33. ncbi request reprint Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes
    H Gobel
    Kiel Pain Clinic, Germany Department of Neurology, University of Kiel, Germany
    Headache 41:264-70. 2001
    ..Rizatriptan has a favorable side effect profile, and, provided contraindications are observed, severe adverse cardiovascular complications are extremely unlikely...
  34. ncbi request reprint Classification of headaches
    H Gobel
    Kiel Pain Clinic, Kiel, Germany
    Cephalalgia 21:770-3. 2001
    ..The IHS classification is the most frequently cited text and one of the most important milestones in the history of the scientific study of headaches...
  35. ncbi request reprint Evidence-based medicine: botulinum toxin A in migraine and tension-type headache
    H Gobel
    Kiel Pain Clinic, Heikendorfer Weg 9 27 D 24149 Kiel, Germany
    J Neurol 248:34-8. 2001
    ..In addition the use of botulinum toxin for cluster-headache and secondary headache is discussed. Further large scale studies will be regarded to demonstrate the long-term efficacy...
  36. ncbi request reprint Practicability and acceptance of subcutaneous self-administration of the selective serotonin agonist sumatriptan
    H Gobel
    Neurological Clinic, Christian Albrecht University, Kiel, Germany
    Headache 38:267-9. 1998
    ..Thus, especially for patients who suffer from severe nausea, vomiting, or diarrhea during migraine attacks, this method of delivery is an easily used means of arresting migraine attacks...